Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

http://scihub22266oqcxt.onion/ 32391999!?!32391999 Warning: file_get_contents(https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&id=32391999&cmd=llinks): Failed to open stream: HTTP request failed! HTTP/1.1 429 Too Many Requests in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 215       Ned+Tijdschr+Geneeskd 2020 ; 164 (?): ? Nephropedia Template TP {{tp|p=32391999|t=2020. Chloroquine als mogelijke behandeling van COVID-19 |pdf=|usr=}}{{32391999}} gab.com Text Chloroquine als mogelijke behandeling van COVID-19 JO: Ned Tijdschr Geneeskd http://www.kidney.de/pget.php?&tw=1&pmid=32391999 #FOAvip Since the outbreak of COVID-19, chloroquine has been mentioned as a possible treatment. In vitro studies have shown anti-viral activity of chloroquine against SARS-CoV-2. Recently, the Dutch National Institute for Public Health and the Environment published treatment options for antiviral treatment for COVID-19 where chloroquine was suggested as first choice for off-label treatment, beside remdesivir en lopinavir/ritonavir. In this commentary, we provide a background and history of chloroquine, the evidence for antiviral efficacy of chloroquine and the arguments for off-label use of chloroquine in COVID-19. Twit Text FOAVip Chloroquine als mogelijke behandeling van COVID-19 ????Ned Tijdschr Geneeskd http://www.kidney.de/pget.php?&tw=1&pmid=32391999 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=32391999 #FOAvip English Wikipedia <ref>{{Cite pmid|32391999}}</ref> Chloroquine als mogelijke behandeling van COVID-19 #MMPMID32391999 Coumou J; de Vries PJ Ned Tijdschr Geneeskd 2020[Mar]; 164 (?): ? PMID32391999show ga Since the outbreak of COVID-19, chloroquine has been mentioned as a possible treatment. In vitro studies have shown anti-viral activity of chloroquine against SARS-CoV-2. Recently, the Dutch National Institute for Public Health and the Environment published treatment options for antiviral treatment for COVID-19 where chloroquine was suggested as first choice for off-label treatment, beside remdesivir en lopinavir/ritonavir. In this commentary, we provide a background and history of chloroquine, the evidence for antiviral efficacy of chloroquine and the arguments for off-label use of chloroquine in COVID-19. |*Betacoronavirus[MESH] |Adenosine Monophosphate/analogs & derivatives/therapeutic use[MESH] |Alanine/analogs & derivatives/therapeutic use[MESH] |Antiviral Agents/*therapeutic use[MESH] |COVID-19[MESH] |Chloroquine/*therapeutic use[MESH] |Coronavirus Infections/*drug therapy[MESH] |Humans[MESH] |Lopinavir/therapeutic use[MESH] |Off-Label Use[MESH] |Pandemics[MESH] |Pneumonia, Viral/*drug therapy[MESH] |Ritonavir/therapeutic use[MESH] |SARS-CoV-2[MESH]Chloroquine als mogelijke behandeling van COVID-19 (epmc).pdf DeepDyve Pubget Overpricing